Cargando…

Use of various immunotherapies for refractory ulcerative colitis in a person living with HIV: a case report

Cancer therapies include several immune checkpoint or anticytokine therapies whereas ulcerative colitis treatments consist of anticytokine therapies. The development of tolerance and immunogical effects of these agents in people living with HIV are not well assessed as these persons are often exclud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costiniuk, Cecilia T, Bessissow, Talat, Isnard, Stéphane, Routy, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846135/ https://www.ncbi.nlm.nih.gov/pubmed/33542833 http://dx.doi.org/10.1093/omcr/omaa131

Ejemplares similares

Differences in HIV burden in the inflamed and non-inflamed colon from a person living with HIV and ulcerative colitis
por: Peng, Xiaorong, et al.
Publicado: (2021)

Angiocentric lymph proliferative disorder (lymphomatoid granulomatosis) in a person with newly-diagnosed HIV infection: a case report
por: Costiniuk, Cecilia T., et al.
Publicado: (2018)

Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)
por: Isnard, Stéphane, et al.
Publicado: (2022)

Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study
por: Royston, Léna, et al.
Publicado: (2023)

The Influence of Oral Terbinafine on Gut Fungal Microbiome Composition and Microbial Translocation in People Living with HIV Treated for Onychomycosis
por: Ouyang, Jing, et al.
Publicado: (2023)

Control of porphyria cutanea tarda with anti-IL-17 secukinumab in a person with psoriasis living with HIV
por: Bedier, Helbies, et al.
Publicado: (2023)

Never say “never the twain shall meet”: Combining antiretroviral therapy and RNA vaccine to obtain an adequate humoral immune response in people living with HIV
por: Routy, Jean-Pierre, et al.
Publicado: (2022)

Cytomegalovirus as an Uninvited Guest in the Response to Vaccines in People Living with HIV
por: Royston, Léna, et al.
Publicado: (2021)

Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis
por: Wetwittayakhlang, Panu, et al.
Publicado: (2021)

Following the elite: Targeting immunometabolism to limit HIV pathogenesis
por: Routy, Jean-Pierre, et al.
Publicado: (2019)

Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?
por: Wetwittayakhlang, Panu, et al.
Publicado: (2021)

Alcohol Use and Abuse Conspires With HIV Infection to Aggravate Intestinal Dysbiosis and Increase Microbial Translocation in People Living With HIV: A Review
por: Yan, Jiangyu, et al.
Publicado: (2021)

Concurrent HIV viral blips during two episodes of multicentric Castleman disease in an adult on antiretroviral therapy: Implication for HIV persistence
por: Darwish, Ilyse, et al.
Publicado: (2021)

Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV
por: Ouyang, Jing, et al.
Publicado: (2023)

Harnessing Autophagy to Overcome Antigen-Specific T-Cell Dysfunction: Implication for People Living with HIV-1
por: Ghahari, Nazanin, et al.
Publicado: (2023)

Beyond the Absence of CD4 T-Cell Count: A Novel Genetic CD4 T-Cell Deficiency Disorder With a Contingency Plan
por: Routy, Jean-Pierre, et al.
Publicado: (2021)

Metformin effect on gut microbiota: insights for HIV-related inflammation
por: Ouyang, Jing, et al.
Publicado: (2020)

Management of Acute Severe Colitis in the Era of Biologicals and Small Molecules
por: Verdon, Christine, et al.
Publicado: (2019)

Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls
por: Ramendra, Rayoun, et al.
Publicado: (2019)

Gut Leakage of Fungal‐Related Products: Turning Up the Heat for HIV Infection
por: Isnard, Stéphane, et al.
Publicado: (2021)

Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study
por: Bessissow, Talat, et al.
Publicado: (2022)

Specific immunotherapy ameliorates ulcerative colitis
por: Cai, Min, et al.
Publicado: (2016)

FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
por: Yero, Alexis, et al.
Publicado: (2022)

GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer
por: Ahmed, Darakhshan Sohail, et al.
Publicado: (2021)

Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
por: Peng, Xiaorong, et al.
Publicado: (2020)

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection
por: Mehraj, Vikram, et al.
Publicado: (2019)

The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation
por: Ouyang, Jing, et al.
Publicado: (2020)

Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV
por: Royston, Léna, et al.
Publicado: (2022)

Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation
por: Ramendra, Rayoun, et al.
Publicado: (2019)

Treatment-refractory ulcerative colitis responsive to indigo naturalis
por: Saiki, Julie P, et al.
Publicado: (2021)

Dynamics and epigenetic signature of regulatory T-cells following antiretroviral therapy initiation in acute HIV infection
por: Yero, Alexis, et al.
Publicado: (2021)

Regulatory T Cells in HIV Infection: Can Immunotherapy Regulate the Regulator?
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2012)

Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection
por: Zaongo, Silvere D, et al.
Publicado: (2023)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
por: Xie, Feng, et al.
Publicado: (2009)

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
por: Pugliese, Daniela, et al.
Publicado: (2016)

Alicaforsen: An Emerging Therapeutic Agent for Ulcerative Colitis and Refractory Pouchitis
por: Hosten, Terron Anthony, et al.
Publicado: (2014)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
por: Chen, An-Yu, et al.
Publicado: (2019)

Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy
por: Mehraj, Vikram, et al.
Publicado: (2014)

Preventative behaviours and COVID-19 infection in a Canadian cohort of people living with HIV
por: Hammond, Keely, et al.
Publicado: (2023)

Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107
por: Lodge, Robert, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s5eq0g1q8a36jdl1416tf473ja